Document Detail

Improvement in antenatal testing for sexually transmissible infections and blood-borne viruses in Western Australian hospitals, 2007 to 2010.
MedLine Citation:
PMID:  22877594     Owner:  NLM     Status:  In-Data-Review    
Objective Antenatal testing for specified sexually transmissible infections (STIs) and blood-borne viruses (BBVs) is recommended by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). In 2007, the Department of Health, Western Australia (DoHWA) issued an operational directive (OD) recommending universal testing for chlamydia and additional testing for women in the STI endemic regions of Western Australia (WA). To assess adherence to these guidelines, seven WA public hospitals were audited. Design and setting: Demographic details and testing information of the last 200 women who gave birth immediately before 30 June 2007 (baseline audit) and 30 June 2010 (follow-up audit) were obtained from each hospital's antenatal records. Results: Data from 2718 women who delivered at ≥36 weeks' gestation were analysed (baselinen=1353; follow-upn=1365). Testing at the first antenatal visit in accordance with the guidelines improved over time (RANZCOG: 68-74%; χ(2)-test = 13.96, d.f.=1, P<0.001; DoHWA OD: 12-40%; χ(2)-test = 279.71, d.f.=1, P<0.001). Retesting at 28-36 weeks' gestation in the STI endemic regions improved for chlamydia (3-10%; χ(2)-test = 17.40, d.f.=1, P<0.001) and gonorrhoea (3-7%; χ(2)-test=6.62, d.f.=1, P<0.05), but not for syphilis or HIV. Chlamydia prevalence was 3% and 8% among nonAboriginal and Aboriginal women, respectively. Conclusion: The proportion of women delivering in WA public hospitals who had antenatal STI and BBV tests improved after publication and promotion of the OD.
Kellie S H Kwan; Carolien M Giele; Barry Combs; Donna B Mak
Related Documents :
23013704 - Fecal immunochemical tests for colorectal cancer screening.
21586254 - Use of middle ear immittance testing in the evaluation of patulous eustachian tube.
21973104 - The diagnostic performance of allergen-molecules in comparison to allergen-extracts.
23576544 - Use of faropenem as an indicator of carbapenemase activity in the enterobacteriaceae.
5309084 - Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensit...
14608804 - Susceptibility testing for bovine respiratory and enteric disease.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Sexual health     Volume:  9     ISSN:  1448-5028     ISO Abbreviation:  Sex Health     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-08-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101242667     Medline TA:  Sex Health     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  349-54     Citation Subset:  IM    
Communicable Disease Control Directorate, Department of Health, Western Australia, PO Box 8172, Perth Business Centre, WA 6849, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Sexual health professionals' evaluations of a prototype computer-based contraceptive planning interv...
Next Document:  Increasing chlamydia diagnoses but little change in hospitalisations for ectopic pregnancy and infer...